These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5937431)

  • 1. [Contribution to the therapy of juvenile and arteriosclerotic chronic peripheral obliterating artery diseases with a new sympatholytic drug].
    Stoppani L; Lo Cuoco A
    Minerva Cardioangiol; 1966 Mar; 14(3):163-5. PubMed ID: 5937431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 3. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
    Cascio F
    Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and hemodynamic aspects induced by eledoisin. Plethysmographic study of variations of flow in some forms of obliterating arterial disease of the legs, during intra-arterial infusion of eledoisin].
    Chiampo L; La Greca G; Ferrari S; Novarini A
    Minerva Cardioangiol; 1965 Jul; 13(7):375-82. PubMed ID: 5838537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A; Borri P; Parravicini R
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment].
    Bagliani A; Borri P; Taborelli R
    Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostacyclin therapy of peripheral artery disease].
    Kusaba A
    Kokyu To Junkan; 1985 Jul; 33(7):871-6. PubMed ID: 3903902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peripheral arterial disease--in the field of internal medicine].
    Seki K
    Nihon Rinsho; 1970 Mar; 28 Suppl():854-5. PubMed ID: 5430911
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasodilation caused by inhibition of calcium ions as a factor of increasing oxygen transport in peripheral vascular diseases].
    Pola P; Savi L; Dal Lago A; Zucchiatti V
    Clin Ter; 1977 Jun; 81(5):417-31. PubMed ID: 884936
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M; Perzanowski A; Myśliwiec M
    Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of mydocalm in the treatment of vascular diseases of the extremities].
    Liubishchev SA
    Klin Med (Mosk); 1967 Jan; 45(1):100-2. PubMed ID: 5613382
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of intrathecal phenol solutions in vascular diseases of the lower exremities].
    Papo I; Visca A
    Minerva Cardioangiol; 1967 Feb; 15(2):169-71. PubMed ID: 5632412
    [No Abstract]   [Full Text] [Related]  

  • 16. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A; Moia R
    Minerva Med; 1978 Apr; 69(19):1287-93. PubMed ID: 662155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 18. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 19. [On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
    Seghezzi R; Borri P; Pedroni G
    Minerva Med; 1968 Dec; 59(99):5458-65. PubMed ID: 5718833
    [No Abstract]   [Full Text] [Related]  

  • 20. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.